BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 22531633)

  • 1. Tumour budding: a promising parameter in colorectal cancer.
    Lugli A; Karamitopoulou E; Zlobec I
    Br J Cancer; 2012 May; 106(11):1713-7. PubMed ID: 22531633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-tumoral budding in preoperative biopsy specimens predicts lymph node and distant metastasis in patients with colorectal cancer.
    Giger OT; Comtesse SC; Lugli A; Zlobec I; Kurrer MO
    Mod Pathol; 2012 Jul; 25(7):1048-53. PubMed ID: 22481282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of perineural invasion in stages II and III colorectal cancer.
    Zhou Y; Wang H; Gong H; Cao M; Zhang G; Wang Y
    Pathol Res Pract; 2015 Nov; 211(11):839-44. PubMed ID: 26429129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer.
    Karamitopoulou E; Zlobec I; Kölzer V; Kondi-Pafiti A; Patsouris ES; Gennatas K; Lugli A
    Mod Pathol; 2013 Feb; 26(2):295-301. PubMed ID: 23018875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential clinical scenarios of tumour budding in colorectal cancer.
    Dawson H; Blank A; Zlobec I; Lugli A
    Acta Gastroenterol Belg; 2019; 82(4):515-518. PubMed ID: 31950807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular invasion, perineural invasion, and tumour budding: predictors of outcome in colorectal cancer.
    Betge J; Langner C
    Acta Gastroenterol Belg; 2011 Dec; 74(4):516-29. PubMed ID: 22319961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and predictive factors in colorectal cancer.
    Zlobec I; Lugli A
    J Clin Pathol; 2008 May; 61(5):561-9. PubMed ID: 18326017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour budding in solid cancers.
    Lugli A; Zlobec I; Berger MD; Kirsch R; Nagtegaal ID
    Nat Rev Clin Oncol; 2021 Feb; 18(2):101-115. PubMed ID: 32901132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological Features and Prognostication in Colorectal Cancer.
    Chen K; Collins G; Wang H; Toh JWT
    Curr Oncol; 2021 Dec; 28(6):5356-5383. PubMed ID: 34940086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern and Significance of Tumour Budding in Colorectal Carcinomas Using ITBCC Guidelines: a Low Resource Setting Practice Observation.
    Ezenkwa US; Ogun GO; Bamiro OO; Mashor MI; Okolo CA; Adegoke OO; Ogunbiyi OJ
    J Gastrointest Cancer; 2020 Sep; 51(3):1018-1023. PubMed ID: 31970654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour border configuration in colorectal cancer: proposal for an alternative scoring system based on the percentage of infiltrating margin.
    Karamitopoulou E; Zlobec I; Koelzer VH; Langer R; Dawson H; Lugli A
    Histopathology; 2015 Oct; 67(4):464-73. PubMed ID: 25648412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive overview of tumour deposits in colorectal cancer: Towards a next TNM classification.
    Delattre JF; Selcen Oguz Erdogan A; Cohen R; Shi Q; Emile JF; Taieb J; Tabernero J; André T; Meyerhardt JA; Nagtegaal ID; Svrcek M
    Cancer Treat Rev; 2022 Feb; 103():102325. PubMed ID: 34954486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer.
    Horcic M; Koelzer VH; Karamitopoulou E; Terracciano L; Puppa G; Zlobec I; Lugli A
    Hum Pathol; 2013 May; 44(5):697-705. PubMed ID: 23159156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.
    Zlobec I; Lugli A
    World J Gastroenterol; 2009 Dec; 15(47):5898-906. PubMed ID: 20014453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of lymphovascular invasion in stage II colorectal cancer patients with an inadequate examination of lymph nodes.
    Gao Z; Cao H; Xu X; Wang Q; Wu Y; Lu Q
    World J Surg Oncol; 2021 Apr; 19(1):125. PubMed ID: 33866973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic and predictive factors in colorectal cancer.
    Zlobec I; Lugli A
    Postgrad Med J; 2008 Aug; 84(994):403-11. PubMed ID: 18832400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies in the pathological assessment of colorectal cancer.
    Maguire A; Sheahan K
    World J Gastroenterol; 2014 Aug; 20(29):9850-61. PubMed ID: 25110416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of tumor budding with clinicopathological features and prognostic value in stage III-IV colorectal cancer.
    Luo YH; Yan ZC; Liu JY; Li XY; Yang M; Fan J; Huang B; Ma CG; Chang XN; Nie X
    World J Gastroenterol; 2024 Jan; 30(2):158-169. PubMed ID: 38312121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour Budding and Survival in Stage II Colorectal Cancer: a Systematic Review and Pooled Analysis.
    Petrelli F; Pezzica E; Cabiddu M; Coinu A; Borgonovo K; Ghilardi M; Lonati V; Corti D; Barni S
    J Gastrointest Cancer; 2015 Sep; 46(3):212-8. PubMed ID: 25994502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can the tumor deposits be counted as metastatic lymph nodes in the UICC TNM staging system for colorectal cancer?
    Song YX; Gao P; Wang ZN; Liang JW; Sun Z; Wang MX; Dong YL; Wang XF; Xu HM
    PLoS One; 2012; 7(3):e34087. PubMed ID: 22461900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.